Correlation Between Boundless Bio, and Supercom

Can any of the company-specific risk be diversified away by investing in both Boundless Bio, and Supercom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Boundless Bio, and Supercom into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Boundless Bio, Common and Supercom, you can compare the effects of market volatilities on Boundless Bio, and Supercom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Boundless Bio, with a short position of Supercom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Boundless Bio, and Supercom.

Diversification Opportunities for Boundless Bio, and Supercom

0.32

Correlation Coefficient

Boundless Bio,  Supercom

Weak diversification

The 3 months correlation between Boundless and Supercom is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Boundless Bio, Common and Supercom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Supercom and Boundless Bio, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Boundless Bio, Common are associated (or correlated) with Supercom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Supercom has no effect on the direction of Boundless Bio, i.e., Boundless Bio, and Supercom go up and down completely randomly.

Pair Corralation between Boundless Bio, and Supercom

Given the investment horizon of 90 days Boundless Bio, Common is expected to under-perform the Supercom. But the stock apears to be less risky and, when comparing its historical volatility, Boundless Bio, Common is 1.21 times less risky than Supercom. The stock trades about -0.12 of its potential returns per unit of risk. The Supercom is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  740.00  in Supercom on September 23, 2024 and sell it today you would lose (401.00) from holding Supercom or give up 54.19% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	69.26%
Values	Daily Returns

Boundless Bio, Common  vs.  Supercom

Boundless Bio, Common

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Boundless Bio, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Supercom

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Supercom has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong fundamental indicators, Supercom is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Boundless Bio, and Supercom

The main advantage of trading using opposite Boundless Bio, and Supercom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Boundless Bio, position performs unexpectedly, Supercom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Supercom will offset losses from the drop in Supercom's long position.

The idea behind Boundless Bio, Common and Supercom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.